Latest News and Press Releases
Want to stay updated on the latest news?
-
Marvel Biosciences Selects Novotech as CRO for Its Phase I Clinical Trial of MB-204, lead asset discovery, a patented neuroactive adenosine A2A antagonist
-
Nasdaq Private Market receives U.S. patent for settlement engine for private company securities, a first for the private market industry
-
Biotech and healthcare innovators are advancing novel therapies and strategic platforms amid rising demand for targeted treatments and efficient global ac
-
Approval in Costa Rica for Kinesiology Tape Products
-
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent
-
CDT Positions for Transformational Growth
-
David Ebrahimzadeh launches Patent Portal, an AI-powered platform for inventors, built from his experience securing multiple U.S. automotive safety patents
-
NorthStrive Biosciences Files 10 U.S. Patent Applications for EL-22 and EL-32 Targeting Muscle Growth and Yield Enhancement in Farmed Animals
-
Distribution agreement
-
New U.S. patent secures long term protection for the Salipro® platform technologies, extending exclusivity until 2042.